BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma L, Gholam Azad M, Dharmasivam M, Richardson V, Quinn RJ, Feng Y, Pountney DL, Tonissen KF, Mellick GD, Yanatori I, Richardson DR. Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol 2021;41:101896. [PMID: 33799121 DOI: 10.1016/j.redox.2021.101896] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Wawrzyniak A, Balawender K, Lalak R, Staszkiewicz R, Boroń D, Grabarek BO. Oligodendrocytes in the periaqueductal gray matter and the corpus callosum in adult male and female domestic sheep. Brain Research 2022;1792:148036. [DOI: 10.1016/j.brainres.2022.148036] [Reference Citation Analysis]
2 Tang Y, Wu J, Xu M, Zhu T, Sun Y, Chen H, Wu L, Chen C. Causal associations of iron status and back pain risk: A Mendelian randomization study. Front Nutr 2022;9:923590. [PMID: 36034918 DOI: 10.3389/fnut.2022.923590] [Reference Citation Analysis]
3 Sweta, Singh B. A review on heavy metal and metalloid contamination of vegetables: addressing the global safe food security concern. International Journal of Environmental Analytical Chemistry. [DOI: 10.1080/03067319.2022.2115890] [Reference Citation Analysis]
4 Sandoval A, Duran P, Corzo-López A, Fernández-Gallardo M, Muñoz-Herrera D, Leyva-Leyva M, González-Ramírez R, Felix R. The role of voltage-gated calcium channels in the pathogenesis of Parkinson's disease. Int J Neurosci 2022;:1-21. [PMID: 35993158 DOI: 10.1080/00207454.2022.2115905] [Reference Citation Analysis]
5 Carota G, Distefano A, Spampinato M, Giallongo C, Broggi G, Longhitano L, Palumbo GA, Parenti R, Caltabiano R, Giallongo S, Di Rosa M, Polosa R, Bramanti V, Vicario N, Li Volti G, Tibullo D. Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models. Antioxidants 2022;11:1596. [DOI: 10.3390/antiox11081596] [Reference Citation Analysis]
6 Mitra J, Kodavati M, Provasek VE, Rao KS, Mitra S, Hamilton DJ, Horner PJ, Vahidy FS, Britz GW, Kent TA, Hegde ML. SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations. Ageing Res Rev 2022;80:101687. [PMID: 35843590 DOI: 10.1016/j.arr.2022.101687] [Reference Citation Analysis]
7 Vrijsen S, Vrancx C, Del Vecchio M, Swinnen JV, Agostinis P, Winderickx J, Vangheluwe P, Annaert W. Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites. Front Neurosci 2022;16:900338. [DOI: 10.3389/fnins.2022.900338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vo VTA, Kim S, Hua TNM, Oh J, Jeong Y. Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment. Commun Biol 2022;5:593. [PMID: 35710828 DOI: 10.1038/s42003-022-03538-y] [Reference Citation Analysis]
9 David S, Ryan F, Jhelum P, Kroner A. Ferroptosis in Neurological Disease. Neuroscientist 2022;:10738584221100183. [PMID: 35678019 DOI: 10.1177/10738584221100183] [Reference Citation Analysis]
10 Tang W, Li Y, He S, Jiang T, Wang N, Du M, Cheng B, Gao W, Li Y, Wang Q. Caveolin-1 Alleviates Diabetes-Associated Cognitive Dysfunction Through Modulating Neuronal Ferroptosis-Mediated Mitochondrial Homeostasis. Antioxid Redox Signal 2022. [PMID: 35350885 DOI: 10.1089/ars.2021.0233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Dusek P, Hofer T, Alexander J, Roos PM, Aaseth JO. Cerebral Iron Deposition in Neurodegeneration. Biomolecules 2022;12:714. [DOI: 10.3390/biom12050714] [Reference Citation Analysis]
12 Foley PB, Hare DJ, Double KL. A brief history of brain iron accumulation in Parkinson disease and related disorders. J Neural Transm (Vienna) 2022. [PMID: 35534717 DOI: 10.1007/s00702-022-02505-5] [Reference Citation Analysis]
13 Rosenblum SL, Kosman DJ. Aberrant Cerebral Iron Trafficking Co-morbid With Chronic Inflammation: Molecular Mechanisms and Pharmacologic Intervention. Front Neurol 2022;13:855751. [DOI: 10.3389/fneur.2022.855751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang Z, Yuan L, Li W, Li J. Ferroptosis in Parkinson’s disease: glia–neuron crosstalk. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Boag MK, Roberts A, Uversky VN, Ma L, Richardson DR, Pountney DL. Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease. Int J Mol Sci 2022;23:2378. [PMID: 35216492 DOI: 10.3390/ijms23042378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sterling JK, Kam TI, Guttha S, Park H, Baumann B, Mehrabani-Tabari AA, Schultz H, Anderson B, Alnemri A, Chou SC, Troncoso JC, Dawson VL, Dawson TM, Dunaief JL. Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological α-synuclein. Cell Rep 2022;38:110358. [PMID: 35172141 DOI: 10.1016/j.celrep.2022.110358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Phan LMT, Hoang TX, Cho S. Fluorescent Carbon Dots for Sensitive and Rapid Monitoring of Intracellular Ferrous Ion. Biosensors (Basel) 2022;12:41. [PMID: 35049669 DOI: 10.3390/bios12010041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Behl T, Madaan P, Sehgal A, Singh S, Anwer MK, Makeen HA, Albratty M, Mohan S, Bungau S. Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease. Int J Mol Sci 2022;23:678. [PMID: 35054862 DOI: 10.3390/ijms23020678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Forero-rodríguez LJ, Josephs-spaulding J, Flor S, Pinzón A, Kaleta C. Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach. Antioxidants 2022;11:71. [DOI: 10.3390/antiox11010071] [Reference Citation Analysis]
20 Fedotcheva TA, Sheichenko OP, Fedotcheva NI. New Properties and Mitochondrial Targets of Polyphenol Agrimoniin as a Natural Anticancer and Preventive Agent. Pharmaceutics 2021;13:2089. [PMID: 34959369 DOI: 10.3390/pharmaceutics13122089] [Reference Citation Analysis]
21 Boag MK, Ma L, Mellick GD, Pountney DL, Feng Y, Quinn RJ, Liew AW, Dharmasivam M, Azad MG, Afroz R, Richardson DR. Calcium channels and iron metabolism: A redox catastrophe in Parkinson's disease and an innovative path to novel therapies? Redox Biol 2021;47:102136. [PMID: 34653841 DOI: 10.1016/j.redox.2021.102136] [Reference Citation Analysis]
22 Riederer P, Monoranu C, Strobel S, Iordache T, Sian-Hülsmann J. Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease. J Neural Transm (Vienna) 2021;128:1577-98. [PMID: 34636961 DOI: 10.1007/s00702-021-02414-z] [Reference Citation Analysis]
23 David S, Jhelum P, Ryan F, Jeong SY, Kroner A. Dysregulation of iron homeostasis in the CNS and the role of ferroptosis in neurodegenerative disorders. Antioxid Redox Signal 2021. [PMID: 34569265 DOI: 10.1089/ars.2021.0218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]